Press release
US Melanoma Market Analysis by Key Players like Amgen, Inc., Bristol-Myers Squibb, Novartis International AG. Pfizer etc. Focusing on Growth Strategies and Upcoming Trends till 2023
US Melanoma Market
About 98% of melanoma is localized in the US. Skin cancer are most common cancers in the US. Treatment available for melanoma include biologic therapy, immune therapy, radiation therapy, chemotherapy and surgery. Ultra violet exposure is known as risk factor of melanoma. Superficial spreading melanoma is the type of melanoma affecting large number of people in the US. The disease is more common in men than women.
The US market of melanoma is expected to reach US$ 3.2 billion in 2023 from US$ 2.4 billion in 2016 with a CAGR of approximately 8.3%.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/2950
US Melanoma Market - Key Players
Some of the Key Players in this market are: Amgen, Inc., Bristol-Myers Squibb, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., Genentech Inc. Janssen Biotech, Inc., and Novartis International AG. Pfizer, Vical and Ziopharm.
US Melanoma Market - Intended Audience
Hospitals
Pharmaceutical companies
Research and development (R&D) companies
Academic medical institutes and universities
Melanoma drug manufactures
Melanoma drug suppliers
US Melanoma Market - Segments
US melanoma market has been segmented on the basis of type (superficial spreading, nodular, lentigo maglina, acral lentigious and others), by gender (male and female), by treatment (immunotherapy, biologic therapy, radiation therapy, chemotherapy, surgery and others), by diagnosis (ABCDE, ugly duckling, biopsy, and others) and by end users (hospitals, pharmaceutical companies, research centers, clinics, laboratories).
US Melanoma Market - Regional Analysis
Melanoma market in the US is divided into states comprising of Georgia, New Jersey, North Carolina, New York, Florida, Illinois, Ohio, Pennsylvania, Texas, Washington, California and, Virginia and Rest of US. California accounts for the largest market for melanoma in US followed by Florida and Ohio. California and Florida are key regions for melanoma market. Large number of melanoma cases are found in this region. New York is the third largest market after Florida. According to American Society of Dermatology, prevalence of melanoma is gradually increasing. and this spreads across the body. Number of skin cancer patients is growing steadily in Florida and Texas. This is due to their exposure to ultraviolet rays and extensive use of tanning beds in these regions. Technological advancement in the field of treatment and diagnosis of melanoma in the US also drives this market. The Food and Drug Administration (FDA) classifies tanning beds as "moderate risk" devices.
Browse Complete 50 Pages Premium Research Report Enabled with Tables and Figures @ https://www.marketresearchfuture.com/reports/us-melanoma-market-2950
Major Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
Continued….
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release US Melanoma Market Analysis by Key Players like Amgen, Inc., Bristol-Myers Squibb, Novartis International AG. Pfizer etc. Focusing on Growth Strategies and Upcoming Trends till 2023 here
News-ID: 1368233 • Views: …
More Releases from Market Research Future
Intelligent Process Automation Market to Reach USD 30 Billion by 2035, Growing a …
The Intelligent Process Automation Market is poised for sustained expansion, with its value rising from USD 8.99 billion in 2024 to USD 30.0 billion by 2035. This growth reflects a strong compound annual growth rate (CAGR) of 11.58% between 2025 and 2035.
Intelligent process automation combines robotic process automation, artificial intelligence, natural language processing, and machine learning to create adaptive, efficient, and resilient business processes. Its adoption is accelerating as…
Chinese Language Education for K-12 Market to Grow at 12.8% CAGR, Hitting USD 16 …
The Chinese Language Education for K-12 Market is experiencing robust expansion as global interest in Chinese language proficiency continues to rise. According to Market Research Future, the market size was valued at USD 4,400.48 million in 2024 and is projected to grow from USD 4,941.74 million in 2025 to USD 16,612.10 million by 2035. This trajectory reflects a strong compound annual growth rate (CAGR) of 12.8% during the forecast period…
Computer Aided Engineering Market to Reach USD 28.78 Billion by 2035, Growing at …
The Computer Aided Engineering Market is entering a decade of strong expansion, underpinned by the growing demand for simulation technologies, design optimization, and advanced product development across industries. According to Market Research Future, the Computer Aided Engineering Market was valued at USD 11.09 billion in 2024 and is projected to grow from USD 11.83 billion in 2025 to USD 28.78 billion by 2035, reflecting a robust compound annual growth rate…
B2B Cybersecurity Market to Hit USD 29.52 Billion by 2034, Growing at 14.32% CAG …
As per Market Research Future Analysis, the B2B Cybersecurity Market is set for remarkable expansion, projected to grow from USD 8,853.54 Million in 2025 to USD 29,527.37 Million by 2034, achieving a compound annual growth rate (CAGR) of 14.32% during the forecast period. The market was valued at USD 7,744.50 Million in 2024, demonstrating a strong base of demand driven by the rising frequency of cyberattacks, growing regulatory pressure, and…
More Releases for Melanoma
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
The Metastatic Melanoma Therapeutics Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Metastatic Melanoma Therapeutics Market Size During the Forecast Period?
The market size for therapeutics in metastatic melanoma has swiftly increased in the past few years. It is projected to augment…
Rising Incidence Of Melanoma Cases Boosts Metastatic Melanoma Therapeutics Marke …
What combination of drivers is leading to accelerated growth in the metastatic melanoma therapeutics market?
The growth of the metastatic melanoma therapeutics market is anticipated to be fueled by the increasing prevalence of melanoma cases. Melanoma, a type of skin cancer, originates in the cells, known as melanocytes, that determine the skin's pigment. Melanomas can develop on any part of the skin. Metastatic melanoma therapeutics comprise various treatments designed to interrupt…
Key Influencer in the Melanoma Therapeutics Market 2025: Surge In Melanoma Incid …
How Are the key drivers contributing to the expansion of the melanoma therapeutics market?
The rise in melanoma cases is predicted to fuel the expansion of the melanoma therapeutics market. Melanoma, a type of skin cancer, begins in the melanocytes. The therapies and medications used to treat melanoma patients and mitigate the effects of cancer are known as melanoma therapeutics. An increase in melanoma cases, therefore, leads to a surge in…
Skin Cancer Market By Cancer Type (Melanoma, Non-melanoma)
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00018117/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
• Pfizer Inc.
• Bristol-Myers Squibb Company
• Abbott Laboratories
• Amgen, Inc.
• Merck & Co., Inc.
• Novartis AG
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Qiagen NV
• Sun Pharmaceutical Industries Ltd…
Melanoma Diagnostics Market - Shining Light on Melanoma: Transforming Lives with …
Newark, New Castle, USA - new report, titled Melanoma Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Melanoma Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Melanoma Diagnostics market. The report offers an overview of the market, which…
Intraocular Melanoma Treatment Market Drivers
Neurological disorder diagnostics tools are medical devices, which are used in diagnosis of various neurological disorders such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and Multiple Sclerosis. The devices which are majorly used in diagnosis are imaging tools such as Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and in-vitro diagnostics tools such as biomarker and biopsy. Increasing prevalence of neurological disorders in the recent past has increased demand for diagnostic…
